About Vitelo
A new model for specialist access, built for the world's underserved markets.
Vitelo is a telehealth platform designed to connect patients with remote specialists at the point of primary care. It is developed and operated by AI Medical City Limited, a company incorporated in England and Wales, and is part of the AI Medical Holding Limited group.
Why Vitelo exists
In most of the world, access to a specialist is determined not by clinical need but by geography. Patients in secondary cities, rural areas, and underserved communities wait months for appointments that patients in major urban centres receive in days. Vitelo exists to change that. By connecting a local doctor and a remote specialist through a secure clinical platform, Vitelo makes specialist-level care available at any facility with a qualified clinician and an internet connection.
Intended capability
Vitelo is currently in development. The services described on this website represent the intended capability of the platform. Vitelo is not yet operational as a clinical service. All clinical services will be subject to applicable regulatory requirements in each market before launch.
Corporate structure
Operating company
AI Medical City Limited
AI Medical City Limited is the operating company for the Vitelo platform. It is incorporated in England and Wales and is responsible for the development and operation of the Vitelo clinical technology platform and the clinical governance framework that underpins it.
Parent company
AI Medical Holding Limited
AI Medical Holding Limited is the parent company of AI Medical City Limited. The holding company structure supports the group's intended international expansion into South Asia and the Gulf.
What guides us
01
Access as a clinical imperative
We believe that access to specialist care is a clinical need, not a privilege. The Vitelo model is designed to make specialist assessment available to patients regardless of where they live.
02
Clinicians at the centre
Technology in the Vitelo platform exists to support clinicians, not to replace them. Every clinical decision is made by a qualified, registered medical practitioner. This is a design principle, not a disclaimer.
03
Governance without compromise
Vitelo operates within established clinical governance frameworks. We do not trade safety for scale. Clinical governance standards apply equally in every market we intend to enter.
04
Transparency about what we are
Vitelo is a platform in development. We are transparent about what the platform currently does, what it intends to do, and what it does not do. We do not overstate our capability or our operational status.
Leadership
Vitelo is led by a team with backgrounds in clinical medicine, health technology, and international healthcare development.
Dr Suhail Chughtai FRCS
Founder Chairman
Dr Chughtai is a consultant surgeon with extensive experience in clinical practice and healthcare development across the UK, South Asia, and the Middle East. He founded AI Medical City Limited to address the gap in access to specialist-level care in underserved markets, and provides strategic leadership across the Vitelo platform.
Ms Jasmin Young MBA
co.founder & chief operating officer
Ms Young co-founded Vitelo and leads the operational delivery of the platform. She is responsible for the end-to-end service infrastructure, partner relationships, and the systems that ensure clinical services are delivered consistently and to the standards the Vitelo governance framework requires.
Dr Arlen Meyers MD
Chief medical officer
Dr Meyers brings broad experience in clinical medicine and health innovation. As Chief Medical Officer, he leads the design of Vitelo's clinical pathways, oversees the integration of AI-assisted tools into clinical workflows, and is responsible for ensuring that every service delivered through the platform meets the standards of safe, evidence-based care.
Mr David Wright
Chief Operating Officer
Mr Wright brings extensive experience in healthcare operations and international service delivery. At Vitelo, he oversees the operational infrastructure of the platform, the coordination of clinical and administrative workflows, and the processes that ensure services are delivered reliably and in accordance with Vitelo's governance standards.
Dr Mateen Ellahi
Chief Clinical Safety Officer
Dr Ellahi leads Vitelo's clinical safety function, with responsibility for the identification, assessment, and management of clinical risk across the platform. He ensures that patient safety standards are embedded in the design and operation of all Vitelo clinical services, and that the platform's safety framework meets the requirements of established clinical governance practice.
Prof Martin Curley
Chief Technology Officer
Prof Curley is a recognised authority in health technology innovation and digital transformation, with a distinguished record spanning academic research, clinical systems development, and international health policy. At Vitelo, he leads the strategic development of the technology platform, guiding the architecture of AI-assisted tools, remote monitoring systems, and the clinical data infrastructure that underpins the Vitelo model.
Work with us
Vitelo is building a team of clinicians, technologists, and health system specialists to support its intended expansion. If you are interested in working with Vitelo or partnering with us, we would like to hear from you.